Key result
Cisplatin-based chemotherapy triggers embolic stroke from rare ascending aortic mural thrombus.
Why the study?
Aortic mural thrombus is a rare complication of cisplatin-based chemotherapy that carries a risk of embolic stroke.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Case report reveals embolic stroke caused by aortic mural thrombus after cisplatin chemotherapy in lung cancer, highlighting rare vascular thrombotic complications.
A 59-year-old woman with small-cell lung carcinoma achieved tumor disappearance after cisplatin-based chemotherapy (CBC) and radiation treatment but subsequently experienced right hemiparesis and aphasia. Brain magnetic resonance imaging revealed a left middle cerebral artery territory acute infarction and left internal carotid artery occlusion. Ultrasonography revealed a mobile thrombus in the left common and internal carotid arteries, and contrast computed tomography revealed a mural thrombus in the ascending aorta. Based on these findings, embolic stroke due to aortic mural thrombus following CBC was diagnosed. Aortic mural thrombus is a rare complication of CBC but carries a risk of embolic stroke.
No takes yet. Share an insight, caveat, or question.
Ochiai et al. (2020) conducted a case report in Small-cell lung carcinoma (n=1). Cisplatin-based chemotherapy was evaluated. Cisplatin-based chemotherapy was followed by the development of an embolic stroke due to a rare nonaneurysmal mural thrombus in the ascending aorta in a 59-year-old woman with small-cell lung cancer.
Synapse has enriched 10 related papers. Consider them for comparative context: